Foghorn Therapeutics Inc.

NASDAQ: FHTX · Real-Time Price · USD
5.02
-0.13 (-2.43%)
At close: Aug 15, 2025, 3:59 PM
5.07
1.00%
After-hours: Aug 15, 2025, 05:10 PM EDT

Foghorn Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-75.39M -80.44M -86.62M -91.22M -86.45M -92.95M -98.43M -103.21M -114.63M -112.46M -108.88M -109.14M -109.45M -105.25M -101.32M -92.94M -85.22M -77.83M
Depreciation & Amortization
3.17M 3.12M 3.13M 3.22M 3.35M 3.43M 3.45M 3.45M 3.43M 3.37M 3.32M 3.28M 3.3M 3.27M 3.23M 2.98M 2.37M 1.84M
Stock-Based Compensation
10.93M 11.36M 11.89M 12.46M 13.54M 14.84M 16.19M 16.92M 16.62M 15.66M 14.34M 12.64M 11.21M 9.74M 8.38M 7.38M 5.88M 4.33M
Other Working Capital
-21.9M -30.73M -29.79M -29.34M -43.52M -43.1M -42.73M 258.95M 276.69M 280.62M 280.84M 22.84M 23.86M 28.48M 33.31M 4.07M 21.85M 24.25M
Other Non-Cash Items
-6.56M 8.82M 14.58M 20.61M 22.34M 14.89M 8.94M 4.55M 3.05M 2.9M 3.62M 3.27M 4.56M 4.61M 4.61M 4.62M 4.99M 4.91M
Deferred Income Tax
n/a n/a n/a -4.99M -5.64M -6.37M -6.37M -1.38M -731K n/a n/a 1.33M 1.43M 1.43M 1.41M 97K 67K 72K
Change in Working Capital
-22.64M -32.3M -32.27M -32.38M -45.65M -44.58M -41.88M -39.81M -20.01M -18.25M 281.55M 323.37M 323.19M 330.64M 33.44M 5.08M 22.35M 23M
Operating Cash Flow
-90.49M -95.03M -100.41M -103.43M -109.63M -116.27M -118.11M -119.49M -112.27M -109.1M 193.61M 234.42M 233.9M 244.43M -50.25M -72.79M -49.56M -43.67M
Capital Expenditures
-838K -833K -906K -464K -237K -689K -1.22M -1.46M -1.7M -1.6M -1.21M -1.02M -921K -1.77M -3.31M -10.72M -15.92M -16.96M
Cash Acquisitions
n/a n/a n/a -1K n/a -39.6M -39.6M -33.36M -79.75M -40.14M -40.14M -46.38M n/a n/a n/a n/a n/a n/a
Purchase of Investments
-257.37M -281.33M -261.47M -228.66M -108.07M -78.93M -73.9M -111.4M -117.16M -223.28M -409.35M -375.25M -412.73M -285.81M -99.98M -182.72M -135.62M -119.45M
Sales Maturities Of Investments
282.42M 254.57M 232.47M 214.32M 193.23M 221.66M 219.57M 213.41M 227.05M 169.47M 166.23M 148.13M 92.13M 167.6M 139.47M 119.47M 119.47M 25M
Other Investing Acitivies
n/a -17.96M 9.24M 46.66M 85.17M 142.73M 115.53M 71.87M 79.75M -83.95M -243.11M -227.12M -320.6M -118.21M 39.49M 29.98M 77.08M -1.22M
Investing Cash Flow
24.21M -27.6M -29.9M -14.81M 84.93M 142.04M 144.45M 100.56M 108.18M -55.41M -244.32M -228.14M -321.52M -119.97M 36.17M -73.72M -31.82M -111.15M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 4.77M 4.77M 4.77M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
1.31M 104.26M 105.43M 104.17M 105.95M 2.84M 1.78M 1.61M 554K 1.48M 1.76M 23.49M 23.66M 22.74M 22.42M 124.42M 122.74M 170.59M
Financial Cash Flow
1.45M 104.4M 105.43M 105.61M 105.95M 2.84M 1.78M 1.61M 554K 1.48M 1.76M 23.49M 23.66M 22.74M 22.42M 129.19M 169.44M 217.29M
Net Cash Flow
-64.83M -18.23M -24.88M -12.63M 81.24M 28.61M 28.12M -17.32M -3.53M -163.03M -48.95M 29.76M -63.96M 147.2M 8.34M -17.32M 88.06M 62.46M
Free Cash Flow
-91.33M -95.86M -101.31M -103.89M -109.87M -116.96M -119.33M -120.94M -113.97M -110.7M 192.4M 233.4M 232.98M 242.66M -53.56M -83.51M -65.48M -60.63M